Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives
Thousands of lives will be saved thanks to more blood pressure checks in high street […]
Alder Hey Launches First Startup Collaboration Programme
Today, Alder Hey Children’s NHS Foundation Trust is launching our first start-up accelerator programme: Alder […]
Musculoskeletal (MSK) Funding Opens
Funding has been created to support Integrated Care Systems (ICSs) who have an active interest […]
Royal Wolverhampton NHS Trust (RWT) and Babylon bring digital-first, value-based healthcare to over 55,000 people across Wolverhampton
Royal Wolverhampton NHS Trust (RWT) and Babylon today announced they have extended their partnership to bring […]
NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England
NHS comment as the latest vaccine statistics published today show that 75% of people aged […]
Nightlife Industry Joins Covid-19 Vaccine Push for Young People
Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]
Around 20 Million People Unaware of Plan to Share GP Medical Records with NHS Database, Which? Finds
Almost half (45%) of adults in England, around 20 million people, are unaware of plans […]
Trust Laboratory is First in the NHS to go Fully Digital
A laboratory at North West Anglia NHS Foundation Trust has been given an award by […]
NHS COVID-19 App Updated to Notify Fewer Contacts to Isolate
The public is being urged to continue to use the NHS COVID-19 app as changes […]
New State of the Art CT Scanner Unveiled at Maidstone Hospital
A brand-new state of the art CT scanner which provides medical staff with clear sharp […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more